Francesca Barone
2023
In 2023, Francesca Barone earned a total compensation of $706.9K as Chief Scientific Officer at Candel Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $80,560 |
|---|---|
| Option Awards | $89,577 |
| Salary | $413,005 |
| Stock Awards | $110,534 |
| Other | $13,200 |
| Total | $706,876 |
Barone received $413K in salary, accounting for 58% of the total pay in 2023.
Barone also received $80.6K in non-equity incentive plan, $89.6K in option awards, $110.5K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Francesca Barone's compensation ranked 1,613th out of 3,006 executives tracked by ExecPay. In other words, Barone earned more than 46.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,613 out of 3,006 | 46th |
Division Manufacturing | 947 out of 1,650 | 43rd |
Major group Chemicals And Allied Products | 609 out of 918 | 34th |
Industry group Drugs | 593 out of 881 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 161 out of 213 | 24th |
Source: SEC filing on May 30, 2024.
Barone's colleagues
We found two more compensation records of executives who worked with Francesca Barone at Candel Therapeutics in 2023.